KEY POINTS:
Listed biotech company Blis Technologies is looking for cornerstone shareholders to help it to move faster on commercialising its products in international markets.
The company said yesterday it would seek the go-ahead from shareholders at a special meeting in Dunedin on November 8 to allot up to 19.99 per cent of its shares to one or more strategic shareholders.
